Security key
363225202
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 10,463,242
- Total 13F value
- $22,085,893
- Share change
- +555,804
- Put/Call ratio
- 262%
- SEC-reported price per share
- $2.11
- Number of holders
- 84
- Value change
- +$1,798,912
- Number of buys
- 37
- Number of sells
- 37
Open additional details 1 more signal available
Report period
Q2 2025
Institutions
84
Top holders
10
GALT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
GALECTIN THERAPEUTICS INC SEC filings
GALECTIN THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 363225202
Recent filing periods:
Ownership snapshot
Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
James C. Czirr
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5
13F
Highest disclosed value: $2,674,852
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $2.67M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
James C. Czirr
$1.16M
VANGUARD GROUP INC
$2.67M
BlackRock, Inc.
$1.73M
OSAIC HOLDINGS, INC.
$1.49M
GEODE CAPITAL MANAGEMENT, LLC
$1.04M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| James C. Czirr |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,160,550
1,045,541 shares
|
— | 03 Feb 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$2,674,852
2,192,502 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$1,726,191
1,414,911 shares
|
— | 31 Mar 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
—
class O/S missing
|
$1,492,560
1,223,416 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,040,731
852,706 shares
|
— | 31 Mar 2025 |
| Geneos Wealth Management Inc. |
13F
Company
|
—
class O/S missing
|
$516,347
423,235 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
84
Shares
10,463,242
Rows available
84
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
88
Q2 2025 holders
84
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend